Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Neuroprotective/neuroreparative activity of MIS416, a myeloid-directed innate immune therapeutic in Phase 2B trial for the treatment of secondary progressive multiple sclerosis
Multiple Sclerosis
P5 - (-)
333
Authors/Disclosures

PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
Gill Webster, PhD No disclosure on file